Prescription and Over-the-Counter Drug Product List 34TH EDITION Cumulative Supplement Number 08 : August 2014 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST >A> ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE >A> TABLET;ORAL >A> TRIUMEQ >A> + VIIV HLTHCARE EQ 600MG BASE;EQ 50MG N 205551 001 Aug 22, 2014 Aug NEWA BASE;300MG ACARBOSE TABLET;ORAL ACARBOSE >D> AB STRIDES ARCOLAB LTD 25MG A 090912 001 Jul 27, 2011 Aug CAHN >D> AB 50MG A 090912 002 Jul 27, 2011 Aug CAHN >D> AB 100MG A 090912 003 Jul 27, 2011 Aug CAHN >A> AB STRIDES PHARMA 25MG A 090912 001 Jul 27, 2011 Aug CAHN >A> AB 50MG A 090912 002 Jul 27, 2011 Aug CAHN >A> AB 100MG A 090912 003 Jul 27, 2011 Aug CAHN ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CAPSULE;ORAL OXYCODONE AND ACETAMINOPHEN >A> @ ACTAVIS ELIZABETH 500MG;5MG A 040199 001 Dec 30, 1998 Aug CAHN >D> @ ACTAVIS TOTOWA 500MG;5MG A 040199 001 Dec 30, 1998 Aug CAHN TABLET;ORAL OXYCODONE AND ACETAMINOPHEN >D> AA ACTAVIS TOTOWA 325MG;7.5MG A 040800 001 Apr 03, 2012 Aug DISC >A> @ 325MG;7.5MG A 040800 001 Apr 03, 2012 Aug DISC >D> AA 325MG;10MG A 040800 002 Apr 03, 2012 Aug DISC >A> @ 325MG;10MG A 040800 002 Apr 03, 2012 Aug DISC >A> AA RHODES PHARMS 325MG;5MG A 201278 001 Aug 28, 2014 Aug NEWA >A> AA 325MG;7.5MG A 201278 002 Aug 28, 2014 Aug NEWA >A> AA 325MG;10MG A 201278 003 Aug 28, 2014 Aug NEWA ACETAZOLAMIDE SODIUM INJECTABLE;INJECTION ACETAZOLAMIDE SODIUM >D> AP BEDFORD EQ 500MG BASE/VIAL A 040089 001 Feb 28, 1995 Aug CAHN >A> AP EUROHLTH INTL EQ 500MG BASE/VIAL A 040089 001 Feb 28, 1995 Aug CAHN ACETYLCYSTEINE SOLUTION;INHALATION, ORAL ACETYLCYSTEINE >D> AN ROXANE 10% A 072323 001 Apr 30, 1992 Aug DISC >A> @ 10% A 072323 001 Apr 30, 1992 Aug DISC >D> AN 20% A 072324 001 Apr 30, 1992 Aug DISC >A> @ 20% A 072324 001 Apr 30, 1992 Aug DISC ACYCLOVIR TABLET;ORAL ACYCLOVIR >A> AB ZYDUS PHARMS USA INC 400MG A 204314 001 Aug 19, 2014 Aug NEWA >A> AB 800MG A 204314 002 Aug 19, 2014 Aug NEWA ALLOPURINOL SODIUM INJECTABLE;INJECTION ALLOPURINOL SODIUM >D> AP BEDFORD LABS EQ 500MG BASE/VIAL A 076870 001 Aug 26, 2004 Aug CAHN >A> AP EUROHLTH INTL EQ 500MG BASE/VIAL A 076870 001 Aug 26, 2004 Aug CAHN ALPROSTADIL INJECTABLE;INJECTION ALPROSTADIL >D> AP BEDFORD 0.5MG/ML A 074815 001 Jan 20, 1998 Aug CAHN >A> AP EUROHLTH INTL 0.5MG/ML A 074815 001 Jan 20, 1998 Aug CAHN Page 1 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST AMANTADINE HYDROCHLORIDE CAPSULE;ORAL AMANTADINE HYDROCHLORIDE >A> @ ACTAVIS ELIZABETH 100MG A 077659 001 Feb 23, 2006 Aug CAHN >D> @ ACTAVIS TOTOWA 100MG A 077659 001 Feb 23, 2006 Aug CAHN AMIKACIN SULFATE INJECTABLE;INJECTION AMIKACIN SULFATE >D> AP + BEDFORD EQ 50MG BASE/ML A 063313 001 Apr 11, 1994 Aug CAHN >D> AP + EQ 250MG BASE/ML A 063315 001 Apr 11, 1994 Aug CAHN >A> AP + EUROHLTH INTL EQ 50MG BASE/ML A 063313 001 Apr 11, 1994 Aug CAHN >A> AP + EQ 250MG BASE/ML A 063315 001 Apr 11, 1994 Aug CAHN >A> AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL >A> EMULSION;IV (INFUSION) >A> KABIVEN IN PLASTIC CONTAINER >A> FRESENIUS KABI USA 3.3%;29MG/100ML;9.8GM/100ML;96M N 200656 004 Aug 25, 2014 Aug NEWA G/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML) >A> 3.3%;29MG/100ML;9.8GM/100ML;96M N 200656 005 Aug 25, 2014 Aug NEWA G/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1540ML) >A> 3.3%;29MG/100ML;9.8GM/100ML;96M N 200656 006 Aug 25, 2014 Aug NEWA G/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (2053ML) >A> + 3.3%;29MG/100ML;9.8GM/100ML;96M N 200656 007 Aug 25, 2014 Aug NEWA G/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (2566ML) >A> PERIKABIVEN IN PLASTIC CONTAINER >A> FRESENIUS KABI USA 2.4%;20MG/100ML;6.8GM/100ML;68M N 200656 001 Aug 25, 2014 Aug NEWA G/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (1440ML) >A> 2.4%;20MG/100ML;6.8GM/100ML;68M N 200656 002 Aug 25, 2014 Aug NEWA G/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (1920ML) >A> 2.4%;20MG/100ML;6.8GM/100ML;68M N 200656 003 Aug 25, 2014 Aug NEWA G/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML) AMLODIPINE BESYLATE; TELMISARTAN TABLET;ORAL TELMISARTAN AND AMLODIPINE >A> AB MYLAN PHARMS INC EQ 5MG BASE;40MG A 202516 001 Aug 26, 2014 Aug NEWA >A> AB EQ 5MG BASE;80MG A 202516 003 Aug 26, 2014 Aug NEWA >A> AB EQ 10MG BASE;40MG A 202516 002 Aug 26, 2014 Aug NEWA >A> AB EQ 10MG BASE;80MG A 202516 004 Aug 26, 2014 Aug NEWA AMMONIA N-13 INJECTABLE;INTRAVENOUS AMMONIA N 13 >A> AP JOHNS HOPKINS UNIV 30mCi-300mCi/8ML (3.75- A 204514 001 Aug 19, 2014 Aug NEWA 37.5mCi/ML) ASPIRIN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ASPIRIN AND CAFFEINE >A> AA + HIKMA INTL PHARMS 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Aug CAHN >D> AA + HIKMA PHARMS LLC 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Aug CAHN Page 2 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ATAZANAVIR SULFATE CAPSULE;ORAL ATAZANAVIR SULFATE >D> AB TEVA PHARMS USA EQ 100MG BASE A 091673 001 Apr 22, 2014 Aug CTEC >A> EQ 100MG BASE A 091673 001 Apr 22, 2014 Aug CTEC REYATAZ >D> AB BRISTOL MYERS SQUIBB EQ 100MG BASE N 021567 001 Jun 20, 2003 Aug DISC >A> @ EQ 100MG BASE N 021567 001 Jun 20, 2003 Aug DISC ATRACURIUM BESYLATE INJECTABLE;INJECTION ATRACURIUM BESYLATE >D> AP + BEDFORD 10MG/ML A 074901 001 Jul 18, 1997 Aug CAHN >A> AP + EUROHLTH INTL 10MG/ML A 074901 001 Jul 18, 1997 Aug CAHN ATRACURIUM BESYLATE PRESERVATIVE FREE >D> AP + BEDFORD 10MG/ML A 074900 001 Jul 18, 1997 Aug CAHN >A> AP + EUROHLTH INTL 10MG/ML A 074900 001 Jul 18, 1997 Aug CAHN AZATHIOPRINE SODIUM INJECTABLE;INJECTION AZATHIOPRINE SODIUM >D> + BEDFORD EQ 100MG BASE/VIAL A 074419 001 Mar 31, 1995 Aug CAHN >A> + EUROHLTH INTL EQ 100MG BASE/VIAL A 074419 001 Mar 31, 1995 Aug CAHN AZTREONAM INJECTABLE;INJECTION AZTREONAM >D> AP BEDFORD 1GM/VIAL A 065286 001 Mar 23, 2011 Aug CAHN >D> AP 2GM/VIAL A 065286 002 Mar 23, 2011 Aug CAHN >A> AP EUROHLTH INTL 1GM/VIAL A 065286 001 Mar 23, 2011 Aug CAHN >A> AP 2GM/VIAL A 065286 002 Mar 23, 2011 Aug CAHN BACITRACIN INJECTABLE;INJECTION BACITRACIN >A> AP XELLIA PHARMS APS 50,000 UNITS/VIAL A 203177 001 Aug 25, 2014 Aug NEWA BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE TABLET;ORAL BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE >A> AB APOTEX INC 5MG;6.25MG A 078794 001 Aug 21, 2014 Aug NEWA >A> AB 10MG;12.5MG A 078794 002 Aug 21, 2014 Aug NEWA >A> AB 20MG;12.5MG A 078794 003 Aug 21, 2014 Aug NEWA >A> AB 20MG;25MG A 078794 004 Aug 21, 2014 Aug NEWA BEXAROTENE CAPSULE;ORAL >D> BEXAROTENE >D> AB BANNER PHARMACAPS 75MG A 203174 001 Aug 12, 2014 Aug DISC >A> @ 75MG A 203174 001 Aug 12, 2014 Aug DISC TARGRETIN >D> AB + VALEANT LUXEMBOURG 75MG N 021055 001 Dec 29, 1999 Aug CTEC >A> + 75MG N 021055 001 Dec 29, 1999 Aug CTEC BICALUTAMIDE TABLET;ORAL BICALUTAMIDE >A> AB ACTAVIS ELIZABETH 50MG A 078634 001 Aug 28, 2009 Aug CAHN >D> AB ACTAVIS TOTOWA 50MG A 078634 001 Aug 28, 2009 Aug CAHN BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL HALFLYTELY >D> + BRAINTREE 5MG,N/A;N/A,210GM;N/A,0.74GM;N/ N 021551 003 Jul 16, 2010 Aug CFTG A,2.86GM;N/A,5.6GM >A> AA + 5MG,N/A;N/A,210GM;N/A,0.74GM;N/ N 021551 003 Jul 16, 2010 Aug CFTG A,2.86GM;N/A,5.6GM >A> PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE, AND BISACODYL >A> AA NOVEL LABS INC 5MG,N/A;N/A,210GM;N/A,0.74GM;N/ A 202217 001 Aug 20, 2014 Aug NEWA A,2.86GM;N/A,5.6GM Page 3 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST >D> BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE >D> TABLET, CHEWABLE, TABLET, CAPSULE;ORAL >D> HELIDAC >D> + PROMETHEUS LABS 262.4MG,N/A,N/A;N/A,250MG,N/A;N N 050719 001 Aug 15, 1996 Aug DISC /A,N/A,500MG >A> @ 262.4MG,N/A,N/A;N/A,250MG,N/A;N N 050719 001 Aug 15, 1996 Aug DISC /A,N/A,500MG BLEOMYCIN SULFATE INJECTABLE;INJECTION BLEOMYCIN SULFATE >D> AP BEDFORD EQ 15 UNITS BASE/VIAL A 065042 002 Oct 17, 2001 Aug CAHN >D> AP EQ 30 UNITS BASE/VIAL A 065042 001 Oct 17, 2001 Aug CAHN >A> AP EUROHLTH INTL EQ 15 UNITS BASE/VIAL A 065042 002 Oct 17, 2001 Aug CAHN >A> AP EQ 30 UNITS BASE/VIAL A 065042 001 Oct 17, 2001 Aug CAHN BUPRENORPHINE HYDROCHLORIDE INJECTABLE;INJECTION BUPRENORPHINE HYDROCHLORIDE >D> AP BEDFORD EQ 0.3MG BASE/ML A 076931 001 Mar 02, 2005 Aug CAHN >A> AP EUROHLTH INTL EQ 0.3MG BASE/ML A 076931 001 Mar 02, 2005 Aug CAHN BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE TABLET;SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE >A> AB TEVA PHARMS USA EQ 2MG BASE;EQ 0.5MG BASE A 091149 001 Sep 08, 2014 Aug NEWA >A> AB EQ 8MG BASE;EQ 2MG BASE A 091149 002 Sep 08, 2014 Aug NEWA BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL BUPROPION HYDROCHLORIDE >A> AB2 JUBILANT GENERICS 150MG A 202775 001 Oct 11, 2013 Aug CAHN >D> AB2 JUBILANT LIFE 150MG A 202775 001 Oct 11, 2013 Aug CAHN BUSPIRONE HYDROCHLORIDE TABLET;ORAL BUSPIRONE HYDROCHLORIDE >A> AB STRIDES ARCOLAB LTD 5MG A 202330 001 Aug 25, 2014 Aug NEWA >A> AB 10MG A 202330 002 Aug 25, 2014 Aug NEWA >A> AB 15MG A 202330 003 Aug 25, 2014 Aug NEWA >A> AB 30MG A 202330 004 Aug 25, 2014 Aug NEWA CAFFEINE CITRATE SOLUTION;INTRAVENOUS CAFCIT >D> AP + BEDFORD LABS EQ 30MG BASE/3ML (EQ 10MG N 020793 001 Sep 21, 1999 Aug CAHN BASE/ML) >A> AP + EUROHLTH INTL EQ 30MG BASE/3ML (EQ 10MG N 020793 001 Sep 21, 1999 Aug CAHN BASE/ML) SOLUTION;ORAL CAFCIT >D> AA + BEDFORD LABS EQ 30MG BASE/3ML (EQ 10MG N 020793 002 Apr 12, 2000 Aug CAHN BASE/ML) >A> AA + EUROHLTH INTL EQ 30MG BASE/3ML (EQ 10MG N 020793 002 Apr 12, 2000 Aug CAHN BASE/ML) >A> CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE >A> TABLET;ORAL >A> INVOKAMET >A> JANSSEN PHARMS 50MG;500MG N 204353 001 Aug 08, 2014 Aug NEWA >A> 50MG;1GM N 204353 002 Aug 08, 2014 Aug NEWA >A> 150MG;500MG N 204353 003 Aug 08, 2014 Aug NEWA >A> + 150MG;1GM N 204353 004 Aug 08, 2014 Aug NEWA Page 4 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST CARBIDOPA; LEVODOPA TABLET, ORALLY DISINTEGRATING;ORAL CARBIDOPA AND LEVODOPA >D> AB IMPAX LABS 10MG;100MG A 090631 001 Jun 08, 2010 Aug DISC >A> @ 10MG;100MG A 090631 001 Jun 08, 2010 Aug DISC >D> AB 25MG;100MG A 090631 002 Jun 08, 2010 Aug DISC >A> @ 25MG;100MG A 090631 002 Jun 08, 2010 Aug DISC >D> AB 25MG;250MG A 090631 003 Jun 08, 2010 Aug DISC >A> @ 25MG;250MG A 090631 003 Jun 08, 2010 Aug DISC >D> AB MYLAN 25MG;250MG A 078893 003 Sep 18, 2008 Aug CRLD >A> AB + 25MG;250MG A 078893 003 Sep 18, 2008 Aug CRLD >D> PARCOPA >D> AB UCB INC 10MG;100MG A 076699 001 Aug 27, 2004 Aug DISC >A> @ 10MG;100MG A 076699 001 Aug 27, 2004 Aug DISC >D> AB 25MG;100MG A 076699 002 Aug 27, 2004 Aug DISC >A> @ 25MG;100MG A 076699 002 Aug 27, 2004 Aug DISC >D> AB + 25MG;250MG A 076699 003 Aug 27, 2004 Aug DISC >A> @ 25MG;250MG A 076699 003 Aug 27, 2004 Aug DISC CARBOPLATIN INJECTABLE;INJECTION CARBOPLATIN >D> @ BEDFORD 50MG/VIAL A 076099 001 Oct 14, 2004 Aug CAHN >D> @ 150MG/VIAL A 076099 002 Oct 14, 2004 Aug CAHN >D> @ 450MG/VIAL A 076099 003 Oct 14, 2004 Aug CAHN >A> @ EUROHLTH INTL 50MG/VIAL A 076099 001 Oct 14, 2004 Aug CAHN >A> @ 150MG/VIAL A 076099 002 Oct 14, 2004 Aug CAHN >A> @ 450MG/VIAL A 076099 003 Oct 14, 2004 Aug CAHN INJECTABLE;IV (INFUSION) CARBOPLATIN >A> AP ACTAVIS ELIZABETH 50MG/5ML (10MG/ML) A 078732 001 Feb 06, 2012 Aug CAHN >A> AP 150MG/15ML (10MG/ML) A 078732 002 Feb 06, 2012 Aug CAHN >A> AP 450MG/45ML (10MG/ML) A 078732 003 Feb 06, 2012 Aug CAHN >A> AP 600MG/60ML (10MG/ML) A 078732 004 Feb 06, 2012 Aug CAHN >D> AP ACTAVIS TOTOWA 50MG/5ML (10MG/ML) A 078732 001 Feb 06, 2012 Aug CAHN >D> AP 150MG/15ML (10MG/ML) A 078732 002 Feb 06, 2012 Aug CAHN >D> AP 450MG/45ML (10MG/ML) A 078732 003 Feb 06, 2012 Aug CAHN >D> AP 600MG/60ML (10MG/ML) A 078732 004 Feb 06, 2012 Aug CAHN >D> AP BEDFORD LABS 50MG/5ML (10MG/ML) A 077244 001 Oct 15, 2004 Aug CAHN >D> AP 150MG/15ML (10MG/ML) A 077244 002 Oct 15, 2004 Aug CAHN >D> AP 450MG/45ML (10MG/ML) A 077244 003 Oct 15, 2004 Aug CAHN >D> AP 600MG/60ML (10MG/ML) A 077244 004 Jan 20, 2006 Aug CAHN >A> AP EUROHLTH INTL 50MG/5ML (10MG/ML) A 077244 001 Oct 15, 2004 Aug CAHN >A> AP 150MG/15ML (10MG/ML) A 077244 002 Oct 15, 2004 Aug CAHN >A> AP 450MG/45ML (10MG/ML) A 077244 003 Oct 15, 2004 Aug CAHN >A> AP 600MG/60ML (10MG/ML) A 077244 004 Jan 20, 2006 Aug CAHN CEFAZOLIN SODIUM INJECTABLE;INJECTION CEFAZOLIN SODIUM >A> AP ACS DOBFAR EQ 20GM BASE/VIAL A 065306 002 Aug 18, 2014 Aug NEWA CEFTRIAXONE SODIUM INJECTABLE;INJECTION CEFTRIAXONE >D> AP AGILA SPECLTS EQ 10GM BASE/VIAL A 091068 001 Jan 07, 2013 Aug DISC >A> @ EQ 10GM BASE/VIAL A 091068 001 Jan 07, 2013 Aug DISC CHLOROPROCAINE HYDROCHLORIDE INJECTABLE;INJECTION CHLOROPROCAINE HYDROCHLORIDE >D> AP BEDFORD 2% A 040273 001 Sep 09, 1998 Aug CAHN >D> AP 3% A 040273 002 Sep 09, 1998 Aug CAHN >A> AP EUROHLTH INTL 2% A 040273 001 Sep 09, 1998 Aug CAHN >A> AP 3% A 040273 002 Sep 09, 1998 Aug CAHN Page 5 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST CHLORZOXAZONE TABLET;ORAL CHLORZOXAZONE >A> @ ACTAVIS ELIZABETH 500MG A 040113 001 Sep 29, 1995 Aug CAHN >D> @ ACTAVIS TOTOWA 500MG A 040113 001 Sep 29, 1995 Aug CAHN CICLOPIROX SHAMPOO;TOPICAL CICLOPIROX >A> AT ACTAVIS MID ATLANTIC 1% A 090490 001 Nov 24, 2009 Aug CAHN >D> AT WATSON LABS INC 1% A 090490 001 Nov 24, 2009 Aug CAHN CILOSTAZOL TABLET;ORAL CILOSTAZOL >A> @ ACTAVIS ELIZABETH 100MG A 077028 002 Nov 26, 2004 Aug CAHN >D> @ ACTAVIS TOTOWA 100MG A 077028 002 Nov 26, 2004 Aug CAHN CISPLATIN INJECTABLE;INJECTION CISPLATIN >D> AP BEDFORD 1MG/ML A 075036 001 Nov 07, 2000 Aug CAHN >A> AP EUROHLTH INTL 1MG/ML A 075036 001 Nov 07, 2000 Aug CAHN CLADRIBINE INJECTABLE;INJECTION CLADRIBINE >D> AP BEDFORD 1MG/ML A 075405 001 Feb 28, 2000 Aug CAHN >A> AP EUROHLTH INTL 1MG/ML A 075405 001 Feb 28, 2000 Aug CAHN CLONAZEPAM TABLET, ORALLY DISINTEGRATING;ORAL CLONAZEPAM >A> AB SUN PHARM INDS INC 0.125MG A 078654 001 Aug 27, 2014 Aug NEWA >A> AB 0.25MG A 078654 002 Aug 27, 2014 Aug NEWA >A> AB 0.5MG A 078654 003 Aug 27, 2014 Aug NEWA >A> AB 1MG A 078654 004 Aug 27, 2014 Aug NEWA >A> AB 2MG A 078654 005 Aug 27, 2014 Aug NEWA CLOPIDOGREL BISULFATE TABLET;ORAL CLOPIDOGREL BISULFATE >A> AB ACTAVIS ELIZABETH EQ 75MG BASE A 090307 001 May 28, 2013 Aug CAHN >D> AB ACTAVIS TOTOWA EQ 75MG BASE A 090307 001 May 28, 2013 Aug CAHN CYCLOSPORINE INJECTABLE;INJECTION CYCLOSPORINE >D> AP BEDFORD 50MG/ML A 065004 001 Oct 29, 1999 Aug CAHN >A> AP EUROHLTH INTL 50MG/ML A 065004 001 Oct 29, 1999 Aug CAHN CYSTEAMINE BITARTRATE CAPSULE, DELAYED RELEASE;ORAL PROCYSBI >A> RAPTOR INC EQ 25MG BASE N 203389 001 Apr 30, 2013 Aug CAHN >A> + EQ 75MG BASE N 203389 002 Apr 30, 2013 Aug CAHN >D> RAPTOR PHARMS EQ 25MG BASE N 203389 001 Apr 30, 2013 Aug CAHN >D> + EQ 75MG BASE N 203389 002 Apr 30, 2013 Aug CAHN CYTARABINE INJECTABLE;INJECTION CYTARABINE >D> AP BEDFORD 1GM/VIAL A 074245 001 Aug 31, 1994 Aug CAHN >D> AP 2GM/VIAL A 074245 002 Aug 31, 1994 Aug CAHN >D> AP 100MG/VIAL A 071471 001 Aug 02, 1989 Aug CAHN >D> AP 500MG/VIAL A 071472 001 Aug 02, 1989 Aug CAHN >A> AP EUROHLTH INTL 1GM/VIAL A 074245 001 Aug 31, 1994 Aug CAHN >A> AP 2GM/VIAL A 074245 002 Aug 31, 1994 Aug CAHN >A> AP 100MG/VIAL A 071471 001 Aug 02, 1989 Aug CAHN >A> AP 500MG/VIAL A 071472 001 Aug 02, 1989 Aug CAHN Page 6 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST DACARBAZINE INJECTABLE;INJECTION DACARBAZINE >D> AP BEDFORD 200MG/VIAL A 075812 001 Jun 15, 2001 Aug CAHN >D> AP 500MG/VIAL A 075812 002 Oct 31, 2002 Aug CAHN >A> AP EUROHLTH INTL 200MG/VIAL A 075812 001 Jun 15, 2001 Aug CAHN >A> AP 500MG/VIAL A 075812 002 Oct 31, 2002 Aug CAHN DACTINOMYCIN INJECTABLE;INJECTION DACTINOMYCIN >D> AP BEDFORD 0.5MG/VIAL A 090304 001 Mar 16, 2010 Aug CAHN >A> AP EUROHLTH INTL 0.5MG/VIAL A 090304 001 Mar 16, 2010 Aug CAHN DAUNORUBICIN HYDROCHLORIDE INJECTABLE;INJECTION CERUBIDINE >D> AP + BEDFORD EQ 20MG BASE/VIAL A 064103 001 Feb 03, 1995 Aug CAHN >A> AP + EUROHLTH INTL EQ 20MG BASE/VIAL A 064103 001 Feb 03, 1995 Aug CAHN DAUNORUBICIN HYDROCHLORIDE >D> AP + BEDFORD EQ 5MG BASE/ML N 050731 001 Jan 30, 1998 Aug CAHN >A> AP + EUROHLTH INTL EQ 5MG BASE/ML N 050731 001 Jan 30, 1998 Aug CAHN DECITABINE INJECTABLE;INTRAVENOUS DECITABINE >A> AP SANDOZ 50MG/VIAL A 202969 001 Aug 28, 2014 Aug NEWA DEFEROXAMINE MESYLATE INJECTABLE;INJECTION DEFEROXAMINE MESYLATE >D> AP BEDFORD 2GM/VIAL A 078086 002 May 30, 2007 Aug CAHN >D> AP 500MG/VIAL A 078086 001 May 30, 2007 Aug CAHN >A> AP EUROHLTH INTL 2GM/VIAL A 078086 002 May 30, 2007 Aug CAHN >A> AP 500MG/VIAL A 078086 001 May 30, 2007 Aug CAHN DESIPRAMINE HYDROCHLORIDE TABLET;ORAL DESIPRAMINE HYDROCHLORIDE >A> AB ACTAVIS ELIZABETH 10MG A 074430 001 Feb 09, 1996 Aug CAHN >A> AB 25MG A 071601 001 Jun 05, 1987 Aug CAHN >A> AB 50MG A 071588 001 Jun 05, 1987 Aug CAHN >A> AB 75MG A 071602 001 Oct 05, 1987 Aug CAHN >A> AB 100MG A 071766 001 Oct 05, 1987 Aug CAHN >A> AB 150MG A 074430 002 Feb 09, 1996 Aug CAHN >D> AB ACTAVIS TOTOWA 10MG A 074430 001 Feb 09, 1996 Aug CAHN >D> AB 25MG A 071601 001 Jun 05, 1987 Aug CAHN >D> AB 50MG A 071588 001 Jun 05, 1987 Aug CAHN >D> AB 75MG A 071602 001 Oct 05, 1987 Aug CAHN >D> AB 100MG A 071766 001 Oct 05, 1987 Aug CAHN >D> AB 150MG A 074430 002 Feb 09, 1996 Aug CAHN DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION >A> DEXMEDETOMIDINE HYDROCHLORIDE >A> AP MYLAN INSTITUTIONAL EQ 200MCG BASE/2ML (EQ 100MCG A 202881 001 Aug 18, 2014 Aug NEWA BASE/ML) >A> AP PAR STERILE PRODUCTS EQ 200MCG BASE/2ML (EQ 100MCG A 203972 001 Aug 18, 2014 Aug NEWA BASE/ML) PRECEDEX >D> + HOSPIRA EQ 100MCG BASE/ML (EQ100MCG N 021038 001 Dec 17, 1999 Aug CFTG BASE/ML) >A> AP + EQ 200MCG BASE/2ML (EQ 100MCG N 021038 001 Dec 17, 1999 Aug CFTG BASE/ML) Page 7 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST DEXRAZOXANE HYDROCHLORIDE INJECTABLE;INJECTION DEXRAZOXANE HYDROCHLORIDE >D> AP BEDFORD EQ 250MG BASE/VIAL A 076068 001 Sep 28, 2004 Aug CAHN >D> AP EQ 500MG BASE/VIAL A 076068 002 Sep 28, 2004 Aug CAHN >A> AP EUROHLTH INTL EQ 250MG BASE/VIAL A 076068 001 Sep 28, 2004 Aug CAHN >A> AP EQ 500MG BASE/VIAL A 076068 002 Sep 28, 2004 Aug CAHN DICYCLOMINE HYDROCHLORIDE INJECTABLE;INJECTION DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE) >D> AP BEDFORD 10MG/ML A 040465 001 Jun 30, 2003 Aug CAHN >A> AP EUROHLTH INTL 10MG/ML A 040465 001 Jun 30, 2003 Aug CAHN DOBUTAMINE HYDROCHLORIDE INJECTABLE;INJECTION DOBUTAMINE HYDROCHLORIDE >D> AP BEDFORD EQ 12.5MG BASE/ML A 074277 001 Oct 31, 1994 Aug CAHN >A> AP EUROHLTH INTL EQ 12.5MG BASE/ML A 074277 001 Oct 31, 1994 Aug CAHN >D> DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% >D> AP + HOSPIRA EQ 50MG BASE/100ML N 020269 001 Oct 19, 1993 Aug DISC >A> @ EQ 50MG BASE/100ML N 020269 001 Oct 19, 1993 Aug DISC >D> AP + EQ 100MG BASE/100ML N 020269 002 Oct 19, 1993 Aug DISC >A> @ EQ 100MG BASE/100ML N 020269 002 Oct 19, 1993 Aug DISC >D> AP + EQ 200MG BASE/100ML N 020269 003 Oct 19, 1993 Aug DISC >A> @ EQ 200MG BASE/100ML N 020269 003 Oct 19, 1993 Aug DISC DOCETAXEL INJECTABLE;INJECTION DOCETAXEL >D> AP ACCORD HLTHCARE 160MG/8ML (20MG/ML) N 201195 005 Apr 20, 2012 Aug CRLD >A> AP + 160MG/8ML (20MG/ML) N 201195 005 Apr 20, 2012 Aug CRLD DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE SOLUTION/DROPS;OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE >A> AT WATSON LABS INC EQ 2% BASE;EQ 0.5% BASE A 202054 001 Sep 03, 2014 Aug NEWA DOXORUBICIN HYDROCHLORIDE INJECTABLE;INJECTION DOXORUBICIN HYDROCHLORIDE >D> AP + BEDFORD 2MG/ML A 062975 001 Mar 17, 1989 Aug CAHN >D> AP + 10MG/VIAL A 062921 001 Mar 17, 1989 Aug CAHN >D> AP + 20MG/VIAL A 062921 002 Mar 17, 1989 Aug CAHN >D> AP + 50MG/VIAL A 062921 003 Mar 17, 1989 Aug CAHN >D> AP + 200MG/100ML A 064097 001 Sep 13, 1994 Aug CAHN >A> AP + EUROHLTH INTL 2MG/ML A 062975 001 Mar 17, 1989 Aug CAHN >A> AP + 10MG/VIAL A 062921 001 Mar 17, 1989 Aug CAHN >A> AP + 20MG/VIAL A 062921 002 Mar 17, 1989 Aug CAHN >A> AP + 50MG/VIAL A 062921 003 Mar 17, 1989 Aug CAHN >A> AP + 200MG/100ML A 064097 001 Sep 13, 1994 Aug CAHN DOXYCYCLINE HYCLATE INJECTABLE;INJECTION DOXYCYCLINE >D> AP + BEDFORD EQ 100MG BASE/VIAL A 062569 001 Mar 09, 1988 Aug CAHN >D> @ EQ 200MG BASE/VIAL A 062569 002 Mar 09, 1988 Aug CAHN >A> AP + EUROHLTH INTL EQ 100MG BASE/VIAL A 062569 001 Mar 09, 1988 Aug CAHN >A> @ EQ 200MG BASE/VIAL A 062569 002 Mar 09, 1988 Aug CAHN >A> ELIGLUSTAT TARTRATE >A> CAPSULE;ORAL >A> CERDELGA >A> + GENZYME CORP EQ 84MG BASE N 205494 001 Aug 19, 2014 Aug NEWA Page 8 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST >A> EMPAGLIFLOZIN >A> TABLET;ORAL >A> JARDIANCE >A> BOEHRINGER INGELHEIM 10MG N 204629 001 Aug 01, 2014 Aug NEWA >A> + 25MG N 204629 002 Aug 01, 2014 Aug NEWA ENTECAVIR TABLET;ORAL BARACLUDE >D> BRISTOL MYERS SQUIBB 0.5MG N 021797 001 Mar 29, 2005 Aug CFTG >A> AB 0.5MG N 021797 001 Mar 29, 2005 Aug CFTG >D> + 1MG N 021797 002 Mar 29, 2005 Aug CFTG >A> AB + 1MG N 021797 002 Mar 29, 2005 Aug CFTG >A> ENTECAVIR >A> AB TEVA PHARMS USA 0.5MG A 202122 001 Aug 26, 2014 Aug NEWA >A> AB 1MG A 202122 002 Aug 26, 2014 Aug NEWA EPIRUBICIN HYDROCHLORIDE INJECTABLE;INJECTION EPIRUBICIN HYDROCHLORIDE >A> AP ACTAVIS ELIZABETH 10MG/5ML (2MG/ML) A 065445 001 Sep 18, 2008 Aug CAHN >A> AP 50MG/25ML (2MG/ML) A 065445 002 Sep 18, 2008 Aug CAHN >A> AP 200MG/100ML (2MG/ML) A 065445 003 Sep 18, 2008 Aug CAHN >D> AP ACTAVIS TOTOWA 10MG/5ML (2MG/ML) A 065445 001 Sep 18, 2008 Aug CAHN >D> AP 50MG/25ML (2MG/ML) A 065445 002 Sep 18, 2008 Aug CAHN >D> AP 200MG/100ML (2MG/ML) A 065445 003 Sep 18, 2008 Aug CAHN >D> AP BEDFORD 50MG/25ML (2MG/ML) A 065289 001 Jun 27, 2007 Aug CAHN >D> AP 200MG/100ML (2MG/ML) A 065289 002 Jun 27, 2007 Aug CAHN >A> AP EUROHLTH INTL 50MG/25ML (2MG/ML) A 065289 001 Jun 27, 2007 Aug CAHN >A> AP 200MG/100ML (2MG/ML) A 065289 002 Jun 27, 2007 Aug CAHN ERGOCALCIFEROL CAPSULE;ORAL ERGOCALCIFEROL >D> AA STRIDES ARCOLAB LTD 50,000 IU A 090455 001 Aug 03, 2010 Aug CAHN >A> AA STRIDES PHARMA 50,000 IU A 090455 001 Aug 03, 2010 Aug CAHN ESCITALOPRAM OXALATE TABLET;ORAL ESCITALOPRAM OXALATE >A> AB JUBILANT GENERICS EQ 5MG BASE A 202280 001 Sep 12, 2012 Aug CAHN >A> AB EQ 10MG BASE A 202280 002 Sep 12, 2012 Aug CAHN >A> AB EQ 20MG BASE A 202280 003 Sep 12, 2012 Aug CAHN >D> AB JUBILANT ORGANOSYS EQ 5MG BASE A 202280 001 Sep 12, 2012 Aug CAHN >D> AB EQ 10MG BASE A 202280 002 Sep 12, 2012 Aug CAHN >D> AB EQ 20MG BASE A 202280 003 Sep 12, 2012 Aug CAHN ESMOLOL HYDROCHLORIDE INJECTABLE;INJECTION ESMOLOL HYDROCHLORIDE >D> AP BEDFORD LABS 10MG/ML A 076323 001 Aug 10, 2004 Aug CAHN >A> AP EUROHLTH INTL 10MG/ML A 076323 001 Aug 10, 2004 Aug CAHN ETOMIDATE INJECTABLE;INJECTION ETOMIDATE >A> AP EMCURE PHARMS LTD 2MG/ML A 204618 001 Aug 13, 2014 Aug NEWA ETOPOSIDE INJECTABLE;INJECTION ETOPOSIDE >D> AP BEDFORD 20MG/ML A 074290 001 Jul 17, 1995 Aug CAHN >A> AP EUROHLTH INTL 20MG/ML A 074290 001 Jul 17, 1995 Aug CAHN EXEMESTANE TABLET;ORAL EXEMESTANE >A> AB ALVOGEN INC 25MG A 200898 001 Jul 28, 2014 Aug CAHN >D> AB EIRGEN PHARMA LTD 25MG A 200898 001 Jul 28, 2014 Aug CAHN Page 9 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST FENOLDOPAM MESYLATE INJECTABLE;INJECTION FENOLDOPAM MESYLATE >D> AP BEDFORD LABS EQ 10MG BASE/ML A 076582 001 Oct 12, 2004 Aug CAHN >A> AP EUROHLTH INTL EQ 10MG BASE/ML A 076582 001 Oct 12, 2004 Aug CAHN FINASTERIDE TABLET;ORAL FINASTERIDE >A> AB ACTAVIS ELIZABETH 1MG A 078371 001 Nov 05, 2013 Aug CAHN >A> AB 5MG A 077914 001 Mar 28, 2007 Aug CAHN >D> AB ACTAVIS TOTOWA 1MG A 078371 001 Nov 05, 2013 Aug CAHN >D> AB 5MG A 077914 001 Mar 28, 2007 Aug CAHN FLOXURIDINE INJECTABLE;INJECTION FLOXURIDINE >D> AP + BEDFORD 500MG/VIAL A 075387 001 Apr 16, 2000 Aug CAHN >A> AP + EUROHLTH INTL 500MG/VIAL A 075387 001 Apr 16, 2000 Aug CAHN FLUDARABINE PHOSPHATE INJECTABLE;INJECTION FLUDARABINE PHOSPHATE >A> AP ACTAVIS ELIZABETH 50MG/VIAL A 078610 001 Feb 11, 2009 Aug CAHN >D> AP ACTAVIS TOTOWA 50MG/VIAL A 078610 001 Feb 11, 2009 Aug CAHN FLUNISOLIDE AEROSOL, METERED;INHALATION AEROSPAN HFA >D> + MEDA PHARMS INC EQ 78MG BASE/INH N 021247 001 Jan 27, 2006 Aug CPOT >A> + 0.078MG/INH N 021247 001 Jan 27, 2006 Aug CPOT FLUPHENAZINE DECANOATE INJECTABLE;INJECTION FLUPHENAZINE DECANOATE >D> AO BEDFORD 25MG/ML A 074531 001 Aug 30, 1996 Aug CAHN >A> AO EUROHLTH INTL 25MG/ML A 074531 001 Aug 30, 1996 Aug CAHN FLUTICASONE FUROATE >A> POWDER;INHALATION >A> ARNUITY ELLIPTA >A> GLAXOSMITHKLINE 0.1MG/INH N 205625 001 Aug 20, 2014 Aug NEWA >A> + 0.2MG/INH N 205625 002 Aug 20, 2014 Aug NEWA FROVATRIPTAN SUCCINATE TABLET;ORAL FROVA >D> + ENDO PHARMS EQ 2.5MG BASE N 021006 001 Nov 08, 2001 Aug CFTG >A> AB + EQ 2.5MG BASE N 021006 001 Nov 08, 2001 Aug CFTG >A> FROVATRIPTAN SUCCINATE >A> AB MYLAN PHARMS INC EQ 2.5MG BASE A 202931 001 Aug 28, 2014 Aug NEWA FUROSEMIDE INJECTABLE;INJECTION FUROSEMIDE >A> AP EMCURE PHARMS LTD 10MG/ML A 203428 001 Aug 26, 2014 Aug NEWA GANCICLOVIR SODIUM INJECTABLE;INJECTION GANCICLOVIR SODIUM >D> @ BEDFORD EQ 500MG BASE/VIAL A 076222 001 Jul 16, 2003 Aug CAHN >A> @ EUROHLTH INTL EQ 500MG BASE/VIAL A 076222 001 Jul 16, 2003 Aug CAHN GATIFLOXACIN SOLUTION/DROPS;OPHTHALMIC GATIFLOXACIN >A> AT HI-TECH PHARMA CO 0.5% A 203189 001 Sep 03, 2014 Aug NEWA Page 10 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION GEMCITABINE HYDROCHLORIDE >A> AP ACTAVIS ELIZABETH EQ 1GM BASE/VIAL A 079160 002 Jul 25, 2011 Aug CAHN >A> AP EQ 200MG BASE/VIAL A 079160 001 Jul 25, 2011 Aug CAHN >D> AP ACTAVIS TOTOWA EQ 1GM BASE/VIAL A 079160 002 Jul 25, 2011 Aug CAHN >D> AP EQ 200MG BASE/VIAL A 079160 001 Jul 25, 2011 Aug CAHN GLYBURIDE TABLET;ORAL GLYBURIDE >A> @ ACTAVIS ELIZABETH 1.5MG A 075947 001 Nov 14, 2002 Aug CAHN >A> @ 3MG A 075947 002 Nov 14, 2002 Aug CAHN >A> @ 6MG A 075947 003 Nov 14, 2002 Aug CAHN >D> @ ACTAVIS TOTOWA 1.5MG A 075947 001 Nov 14, 2002 Aug CAHN >D> @ 3MG A 075947 002 Nov 14, 2002 Aug CAHN >D> @ 6MG A 075947 003 Nov 14, 2002 Aug CAHN GRANISETRON HYDROCHLORIDE INJECTABLE;INJECTION GRANISETRON HYDROCHLORIDE >A> AP BANNER PHARMACAPS EQ 0.1MG BASE/ML (EQ 0.1MG A 078863 001 Jun 30, 2008 Aug CAHN BASE/ML) >D> AP DSM PHARMS INC EQ 0.1MG BASE/ML (EQ 0.1MG A 078863 001 Jun 30, 2008 Aug CAHN BASE/ML) GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE >A> AP BANNER PHARMACAPS EQ 1MG BASE/ML (EQ 1MG BASE/ML) A 078863 002 Jun 30, 2008 Aug CAHN >D> AP DSM PHARMS INC EQ 1MG BASE/ML (EQ 1MG BASE/ML) A 078863 002 Jun 30, 2008 Aug CAHN HALOPERIDOL DECANOATE INJECTABLE;INJECTION HALOPERIDOL DECANOATE >D> AO BEDFORD EQ 50MG BASE/ML A 074811 001 Jan 30, 1998 Aug CAHN >D> AO EQ 100MG BASE/ML A 075305 001 Sep 28, 1998 Aug CAHN >A> AO EUROHLTH INTL EQ 50MG BASE/ML A 074811 001 Jan 30, 1998 Aug CAHN >A> AO EQ 100MG BASE/ML A 075305 001 Sep 28, 1998 Aug CAHN HALOPERIDOL LACTATE INJECTABLE;INJECTION HALOPERIDOL >D> AP BEDFORD EQ 5MG BASE/ML A 075858 001 Jun 18, 2001 Aug CAHN >A> AP EUROHLTH INTL EQ 5MG BASE/ML A 075858 001 Jun 18, 2001 Aug CAHN HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE TABLET;ORAL HOMATROPRINE METHYLBROMIDE AND HYDROCODONE BITARTRATE >A> @ ACTAVIS ELIZABETH 1.5MG;5MG A 040295 001 Dec 01, 2000 Aug CAHN >D> @ ACTAVIS TOTOWA 1.5MG;5MG A 040295 001 Dec 01, 2000 Aug CAHN HYDRALAZINE HYDROCHLORIDE TABLET;ORAL HYDRALAZINE HYDROCHLORIDE >A> @ ACTAVIS ELIZABETH 25MG A 088560 001 Oct 04, 1984 Aug CAHN >A> @ 50MG A 088649 001 Oct 18, 1984 Aug CAHN >D> @ ACTAVIS TOTOWA 25MG A 088560 001 Oct 04, 1984 Aug CAHN >D> @ 50MG A 088649 001 Oct 18, 1984 Aug CAHN >D> AA STRIDES ARCOLAB LTD 25MG A 200770 001 May 03, 2013 Aug CAHN >D> AA 50MG A 200770 002 May 03, 2013 Aug CAHN >D> AA 100MG A 200770 003 May 03, 2013 Aug CAHN >A> AA STRIDES PHARMA 25MG A 200770 001 May 03, 2013 Aug CAHN >A> AA 50MG A 200770 002 May 03, 2013 Aug CAHN >A> AA 100MG A 200770 003 May 03, 2013 Aug CAHN Page 11 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST HYDROCORTISONE BUTYRATE CREAM;TOPICAL HYDROCORTISONE BUTYRATE >D> AB GLENMARK GENERICS 0.1% A 202145 001 Sep 27, 2013 Aug CTEC >A> AB2 0.1% A 202145 001 Sep 27, 2013 Aug CTEC >D> AB TARO PHARM INDS 0.1% A 076654 001 Aug 03, 2005 Aug CTEC >A> AB1 0.1% A 076654 001 Aug 03, 2005 Aug CTEC LOCOID >D> AB + PRECISION DERMAT 0.1% N 018514 001 Mar 31, 1982 Aug CTEC >A> AB1 + 0.1% N 018514 001 Mar 31, 1982 Aug CTEC LOCOID LIPOCREAM >D> AB + PRECISION DERMAT 0.1% N 020769 001 Sep 08, 1997 Aug CTEC >A> AB2 + 0.1% N 020769 001 Sep 08, 1997 Aug CTEC HYDROXYZINE HYDROCHLORIDE TABLET;ORAL HYDROXYZINE HYDROCHLORIDE >A> @ ACTAVIS ELIZABETH 10MG A 089071 001 Jul 22, 1986 Aug CAHN >A> @ 25MG A 089072 001 Jul 22, 1986 Aug CAHN >A> @ 50MG A 089073 001 Jul 22, 1986 Aug CAHN >D> @ ACTAVIS TOTOWA 10MG A 089071 001 Jul 22, 1986 Aug CAHN >D> @ 25MG A 089072 001 Jul 22, 1986 Aug CAHN >D> @ 50MG A 089073 001 Jul 22, 1986 Aug CAHN >A> AB EMCURE PHARMS USA 10MG A 204279 001 Aug 20, 2014 Aug NEWA >A> AB 25MG A 204279 002 Aug 20, 2014 Aug NEWA >A> AB 50MG A 204279 003 Aug 20, 2014 Aug NEWA IBANDRONATE SODIUM INJECTABLE;INTRAVENOUS IBANDRONATE SODIUM >A> AP AGILA SPECLTS EQ 3MG BASE/3ML A 202671 001 Sep 02, 2014 Aug NEWA >A> AP EMCURE PHARMS LTD EQ 3MG BASE/3ML A 203987 001 Sep 02, 2014 Aug NEWA >A> AP SAGENT PHARMS EQ 3MG BASE/3ML A 202235 001 Sep 02, 2014 Aug NEWA IDARUBICIN HYDROCHLORIDE INJECTABLE;INJECTION IDARUBICIN HYDROCHLORIDE >D> AP BEDFORD LABS 1MG/ML A 065275 001 Dec 14, 2006 Aug CAHN >D> AP 1MG/ML A 065288 001 May 15, 2007 Aug CAHN >A> AP EUROHLTH INTL 1MG/ML A 065275 001 Dec 14, 2006 Aug CAHN >A> AP 1MG/ML A 065288 001 May 15, 2007 Aug CAHN IFOSFAMIDE INJECTABLE;INJECTION IFOSFAMIDE >D> AP BEDFORD LABS 1GM/20ML(50MG/ML) A 076619 001 Jun 29, 2011 Aug CAHN >D> AP 3GM/60ML(50MG/ML) A 076619 002 Jun 29, 2011 Aug CAHN >A> AP EUROHLTH INTL 1GM/20ML(50MG/ML) A 076619 001 Jun 29, 2011 Aug CAHN >A> AP 3GM/60ML(50MG/ML) A 076619 002 Jun 29, 2011 Aug CAHN IMIQUIMOD CREAM;TOPICAL IMIQUIMOD >D> AB STRIDES ARCOLAB LTD 5% A 202002 001 Jun 24, 2014 Aug CAHN >A> AB STRIDES PHARMA 5% A 202002 001 Jun 24, 2014 Aug CAHN INAMRINONE LACTATE INJECTABLE;INJECTION AMRINONE LACTATE >D> + BEDFORD EQ 5MG BASE/ML A 075513 001 May 09, 2000 Aug CAHN >A> + EUROHLTH INTL EQ 5MG BASE/ML A 075513 001 May 09, 2000 Aug CAHN INDOMETHACIN SODIUM INJECTABLE;INJECTION INDOMETHACIN SODIUM >D> AP BEDFORD EQ 1MG BASE/VIAL A 078713 001 Jul 16, 2008 Aug CAHN >A> AP EUROHLTH INTL EQ 1MG BASE/VIAL A 078713 001 Jul 16, 2008 Aug CAHN Page 12 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST IRINOTECAN HYDROCHLORIDE INJECTABLE;INJECTION IRINOTECAN HYDROCHLORIDE >A> AP ACTAVIS ELIZABETH 40MG/2ML (20MG/ML) A 078589 001 Feb 27, 2008 Aug CAHN >A> AP 100MG/5ML (20MG/ML) A 078589 002 Feb 27, 2008 Aug CAHN >D> AP ACTAVIS TOTOWA 40MG/2ML (20MG/ML) A 078589 001 Feb 27, 2008 Aug CAHN >D> AP 100MG/5ML (20MG/ML) A 078589 002 Feb 27, 2008 Aug CAHN KETAMINE HYDROCHLORIDE INJECTABLE;INJECTION KETAMINE HYDROCHLORIDE >D> AP BEDFORD EQ 50MG BASE/ML A 074524 001 Mar 22, 1996 Aug CAHN >D> AP EQ 100MG BASE/ML A 074524 002 Mar 22, 1996 Aug CAHN >A> AP EUROHLTH INTL EQ 50MG BASE/ML A 074524 001 Mar 22, 1996 Aug CAHN >A> AP EQ 100MG BASE/ML A 074524 002 Mar 22, 1996 Aug CAHN LABETALOL HYDROCHLORIDE INJECTABLE;INJECTION LABETALOL HYDROCHLORIDE >D> AP BEDFORD 5MG/ML A 075303 001 May 28, 1999 Aug CAHN >A> AP EUROHLTH INTL 5MG/ML A 075303 001 May 28, 1999 Aug CAHN LAMIVUDINE; ZIDOVUDINE TABLET;ORAL LAMIVUDINE AND ZIDOVUDINE >A> AB MYLAN PHARMS INC 150MG;300MG A 204005 001 Aug 28, 2014 Aug NEWA LAMOTRIGINE TABLET;ORAL LAMOTRIGINE >A> @ ACTAVIS ELIZABETH 25MG A 078669 001 Apr 08, 2011 Aug CAHN >A> @ 100MG A 078669 002 Apr 08, 2011 Aug CAHN >A> @ 150MG A 078669 003 Apr 08, 2011 Aug CAHN >A> @ 200MG A 078669 004 Apr 08, 2011 Aug CAHN >D> @ ACTAVIS TOTOWA 25MG A 078669 001 Apr 08, 2011 Aug CAHN >D> @ 100MG A 078669 002 Apr 08, 2011 Aug CAHN >D> @ 150MG A 078669 003 Apr 08, 2011 Aug CAHN >D> @ 200MG A 078669 004 Apr 08, 2011 Aug CAHN LETROZOLE TABLET;ORAL LETROZOLE >A> @ ACTAVIS ELIZABETH 2.5MG A 090292 001 Jul 13, 2011 Aug CAHN >D> @ ACTAVIS TOTOWA 2.5MG A 090292 001 Jul 13, 2011 Aug CAHN LEUCOVORIN CALCIUM INJECTABLE;INJECTION LEUCOVORIN CALCIUM >D> AP + BEDFORD EQ 50MG BASE/VIAL A 089384 001 Sep 14, 1987 Aug CAHN >D> AP + EQ 100MG BASE/VIAL A 089717 001 Mar 28, 1988 Aug CAHN >A> AP + EUROHLTH INTL EQ 50MG BASE/VIAL A 089384 001 Sep 14, 1987 Aug CAHN >A> AP + EQ 100MG BASE/VIAL A 089717 001 Mar 28, 1988 Aug CAHN LEUCOVORIN CALCIUM PRESERVATIVE FREE >D> + BEDFORD EQ 10MG BASE/ML A 040347 001 Apr 25, 2000 Aug CAHN >D> AP + EQ 200MG BASE/VIAL A 040056 001 May 23, 1995 Aug CAHN >D> AP + EQ 350MG BASE/VIAL A 040335 001 Apr 20, 2000 Aug CAHN >A> + EUROHLTH INTL EQ 10MG BASE/ML A 040347 001 Apr 25, 2000 Aug CAHN >A> AP + EQ 200MG BASE/VIAL A 040056 001 May 23, 1995 Aug CAHN >A> AP + EQ 350MG BASE/VIAL A 040335 001 Apr 20, 2000 Aug CAHN LEVOCARNITINE INJECTABLE;INJECTION LEVOCARNITINE >D> AP BEDFORD 200MG/ML A 075567 001 Mar 29, 2001 Aug CAHN >A> AP EUROHLTH INTL 200MG/ML A 075567 001 Mar 29, 2001 Aug CAHN Page 13 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST LEVOCETIRIZINE DIHYDROCHLORIDE SOLUTION;ORAL LEVOCETIRIZINE DIHYDROCHLORIDE >A> AA APOTEX INC 2.5MG/5ML A 202915 001 Aug 21, 2014 Aug NEWA TABLET;ORAL LEVOCETIRIZINE DIHYDROCHLORIDE >A> AB SCIEGEN PHARMS INC 5MG A 203646 001 Sep 09, 2014 Aug NEWA LEVONORGESTREL TABLET;ORAL LEVONORGESTREL >D> AB WATSON LABS 0.75MG A 078666 001 Jun 24, 2009 Aug DISC >A> @ 0.75MG A 078666 001 Jun 24, 2009 Aug DISC LOMUSTINE CAPSULE;ORAL >D> CEENU >D> CORDEN PHARMA 10MG N 017588 001 Aug 04, 1976 Aug CTNA >D> 40MG N 017588 002 Aug 04, 1976 Aug CTNA >D> + 100MG N 017588 003 Aug 04, 1976 Aug CTNA >A> GLEOSTINE >A> CORDEN PHARMA 10MG N 017588 001 Aug 04, 1976 Aug CTNA >A> 40MG N 017588 002 Aug 04, 1976 Aug CTNA >A> + 100MG N 017588 003 Aug 04, 1976 Aug CTNA LUBIPROSTONE CAPSULE;ORAL AMITIZA >A> SUCAMPO PHARMA LLC 8MCG N 021908 002 Apr 29, 2008 Aug CAHN >A> + 24MCG N 021908 001 Jan 31, 2006 Aug CAHN >D> SUCAMPO PHARMS 8MCG N 021908 002 Apr 29, 2008 Aug CAHN >D> + 24MCG N 021908 001 Jan 31, 2006 Aug CAHN MAFENIDE ACETATE FOR SOLUTION;TOPICAL MAFENIDE ACETATE >D> AB PAR FORM 5% A 201511 001 Feb 12, 2013 Aug CTEC >A> AT 5% A 201511 001 Feb 12, 2013 Aug CTEC SULFAMYLON >D> AB + MYLAN INSTITUTIONAL 5% N 019832 003 Jun 05, 1998 Aug CTEC >A> AT + 5% N 019832 003 Jun 05, 1998 Aug CTEC MEGESTROL ACETATE SUSPENSION;ORAL MEGACE ES >D> + PAR PHARM 125MG/ML N 021778 001 Jul 05, 2005 Aug CFTG >A> AB + 125MG/ML N 021778 001 Jul 05, 2005 Aug CFTG >A> MEGESTROL ACETATE >A> AB TWI PHARMS INC 125MG/ML A 203139 001 Aug 27, 2014 Aug NEWA MELOXICAM TABLET;ORAL MELOXICAM >D> AB STRIDES ARCOLAB LTD 7.5MG A 077928 001 May 13, 2009 Aug CAHN >D> AB 15MG A 077928 002 May 13, 2009 Aug CAHN >A> AB STRIDES PHARMA 7.5MG A 077928 001 May 13, 2009 Aug CAHN >A> AB 15MG A 077928 002 May 13, 2009 Aug CAHN MELPHALAN HYDROCHLORIDE INJECTABLE;INJECTION MELPHALAN HYDROCHLORIDE >D> AP BEDFORD LABS EQ 50MG BASE/VIAL A 090303 001 Oct 28, 2010 Aug CAHN >A> AP EUROHLTH INTL EQ 50MG BASE/VIAL A 090303 001 Oct 28, 2010 Aug CAHN MEMANTINE HYDROCHLORIDE TABLET;ORAL >D> NAMENDA >D> FOREST LABS 5MG N 021487 001 Oct 16, 2003 Aug DISC >A> @ 5MG N 021487 001 Oct 16, 2003 Aug DISC >D> + 10MG N 021487 002 Oct 16, 2003 Aug DISC >A> @ 10MG N 021487 002 Oct 16, 2003 Aug DISC Page 14 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST MESNA INJECTABLE;INTRAVENOUS MESNA >D> AP BEDFORD 100MG/ML A 075739 001 Jan 09, 2004 Aug CAHN >A> AP EUROHLTH INTL 100MG/ML A 075739 001 Jan 09, 2004 Aug CAHN METFORMIN HYDROCHLORIDE TABLET;ORAL METFORMIN HYDROCHLORIDE >A> AB ZYDUS HLTHCARE 1GM A 203686 003 Aug 28, 2014 Aug NEWA >A> AB 500MG A 203686 001 Aug 28, 2014 Aug NEWA >A> AB 850MG A 203686 002 Aug 28, 2014 Aug NEWA METHOTREXATE SODIUM INJECTABLE;INJECTION METHOTREXATE SODIUM >D> AP + BEDFORD EQ 100MG BASE/4ML (EQ 25MG A 089341 001 Sep 16, 1986 Aug CAHN BASE/ML) >D> + EQ 200MG BASE/8ML (EQ 25MG A 089342 001 Sep 16, 1986 Aug CAHN BASE/ML) >A> AP + EUROHLTH INTL EQ 100MG BASE/4ML (EQ 25MG A 089341 001 Sep 16, 1986 Aug CAHN BASE/ML) >A> + EQ 200MG BASE/8ML (EQ 25MG A 089342 001 Sep 16, 1986 Aug CAHN BASE/ML) METHOTREXATE SODIUM PRESERVATIVE FREE >D> + BEDFORD EQ 1GM BASE/VIAL A 040632 001 Aug 12, 2005 Aug CAHN >D> AP + EQ 50MG BASE/2ML (EQ 25MG A 089340 001 Sep 16, 1986 Aug CAHN BASE/ML) >D> AP + EQ 250MG BASE/10ML (EQ 25MG A 089343 001 Sep 16, 1986 Aug CAHN BASE/ML) >A> + EUROHLTH INTL EQ 1GM BASE/VIAL A 040632 001 Aug 12, 2005 Aug CAHN >A> AP + EQ 50MG BASE/2ML (EQ 25MG A 089340 001 Sep 16, 1986 Aug CAHN BASE/ML) >A> AP + EQ 250MG BASE/10ML (EQ 25MG A 089343 001 Sep 16, 1986 Aug CAHN BASE/ML) METHOXSALEN CAPSULE;ORAL METHOXSALEN >D> AB STRIDES ARCOLAB LTD 10MG A 202687 001 Jun 05, 2014 Aug CAHN >A> AB STRIDES PHARMA 10MG A 202687 001 Jun 05, 2014 Aug CAHN METOCLOPRAMIDE HYDROCHLORIDE TABLET, ORALLY DISINTEGRATING;ORAL >A> METOCLOPRAMIDE HYDROCHLORIDE >A> AB NOVEL LABS INC EQ 5MG BASE A 202191 001 Aug 15, 2014 Aug NEWA >A> EQ 10MG BASE A 202191 002 Aug 15, 2014 Aug NEWA METOZOLV ODT >D> + SALIX PHARMS EQ 5MG BASE N 022246 001 Sep 04, 2009 Aug CFTG >A> AB + EQ 5MG BASE N 022246 001 Sep 04, 2009 Aug CFTG METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE;ORAL METOPROLOL SUCCINATE >D> AB REDDYS EQ 100MG BASE A 078889 001 Aug 15, 2012 Aug CPOT >A> AB EQ 100MG TARTRATE A 078889 001 Aug 15, 2012 Aug CPOT >D> AB EQ 200MG BASE A 078889 002 Aug 15, 2012 Aug CPOT >A> AB EQ 200MG TARTRATE A 078889 002 Aug 15, 2012 Aug CPOT METOPROLOL TARTRATE INJECTABLE;INJECTION METOPROLOL TARTRATE >A> AP GLAND PHARMA LTD 1MG/ML A 204205 001 Aug 27, 2014 Aug NEWA MIDAZOLAM HYDROCHLORIDE INJECTABLE;INJECTION MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE >A> AP BD RX EQ 1MG BASE/ML A 203460 001 Aug 22, 2014 Aug NEWA >A> AP EQ 5MG BASE/ML A 203460 002 Aug 22, 2014 Aug NEWA Page 15 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST MILRINONE LACTATE INJECTABLE;INJECTION MILRINONE LACTATE >A> AP HOSPIRA INC EQ 1MG BASE/ML A 203280 001 Sep 03, 2014 Aug NEWA MINOCYCLINE HYDROCHLORIDE CAPSULE;ORAL DYNACIN >A> @ CNTY LINE PHARMS EQ 50MG BASE A 063066 001 Aug 14, 1990 Aug CAHN >D> @ MEDICIS EQ 50MG BASE A 063066 001 Aug 14, 1990 Aug CAHN TABLET, EXTENDED RELEASE;ORAL MINOCYCLINE HYDROCHLORIDE >A> AB MYLAN PHARMS INC EQ 80MG BASE A 203443 002 Aug 22, 2014 Aug NEWA >A> AB EQ 105MG BASE A 203443 003 Aug 22, 2014 Aug NEWA SOLODYN >D> + MEDICIS EQ 80MG BASE N 050808 007 Aug 27, 2010 Aug CTEC >A> AB + EQ 80MG BASE N 050808 007 Aug 27, 2010 Aug CTEC >D> EQ 105MG BASE N 050808 006 Aug 27, 2010 Aug CTEC >A> AB EQ 105MG BASE N 050808 006 Aug 27, 2010 Aug CTEC MIRTAZAPINE TABLET;ORAL MIRTAZAPINE >A> @ ACTAVIS ELIZABETH 15MG A 076241 001 Jun 25, 2003 Aug CAHN >A> @ 30MG A 076241 002 Jun 25, 2003 Aug CAHN >A> @ 45MG A 076241 003 Jun 25, 2003 Aug CAHN >D> @ ACTAVIS TOTOWA 15MG A 076241 001 Jun 25, 2003 Aug CAHN >D> @ 30MG A 076241 002 Jun 25, 2003 Aug CAHN >D> @ 45MG A 076241 003 Jun 25, 2003 Aug CAHN MITOXANTRONE HYDROCHLORIDE INJECTABLE;INJECTION MITOXANTRONE HYDROCHLORIDE >D> AP BEDFORD EQ 20MG BASE/10ML (EQ 2MG A 076611 001 Apr 11, 2006 Aug CAHN BASE/ML) >D> AP EQ 25MG BASE/12.5ML (EQ 2MG A 076611 002 Apr 11, 2006 Aug CAHN BASE/ML) >D> AP EQ 30MG BASE/15ML (EQ 2MG A 076611 003 Apr 11, 2006 Aug CAHN BASE/ML) >A> AP EUROHLTH INTL EQ 20MG BASE/10ML (EQ 2MG A 076611 001 Apr 11, 2006 Aug CAHN BASE/ML) >A> AP EQ 25MG BASE/12.5ML (EQ 2MG A 076611 002 Apr 11, 2006 Aug CAHN BASE/ML) >A> AP EQ 30MG BASE/15ML (EQ 2MG A 076611 003 Apr 11, 2006 Aug CAHN BASE/ML) MOXIFLOXACIN HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC >A> MOXIFLOXACIN HYDROCHLORIDE >A> AT LUPIN LTD EQ 0.5% BASE A 202867 001 Sep 04, 2014 Aug NEWA VIGAMOX >D> + ALCON PHARMS LTD EQ 0.5% BASE N 021598 001 Apr 15, 2003 Aug CFTG >A> AT + EQ 0.5% BASE N 021598 001 Apr 15, 2003 Aug CFTG MYCOPHENOLATE MOFETIL CAPSULE;ORAL MYCOPHENOLATE MOFETIL >D> AB STRIDES ARCOLAB LTD 250MG A 090055 001 Jun 10, 2010 Aug CAHN >A> AB STRIDES PHARMA 250MG A 090055 001 Jun 10, 2010 Aug CAHN TABLET;ORAL MYCOPHENOLATE MOFETIL >D> AB STRIDES ARCOLAB LTD 500MG A 090456 001 Jun 10, 2010 Aug CAHN >A> AB STRIDES PHARMA 500MG A 090456 001 Jun 10, 2010 Aug CAHN MYCOPHENOLIC ACID TABLET, DELAYED RELEASE;ORAL MYCOPHENOLIC ACID >A> AB APOTEX INC 360MG A 091558 002 Aug 19, 2014 Aug NEWA Page 16 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST NAPROXEN SODIUM TABLET, EXTENDED RELEASE;ORAL NAPRELAN >D> ALMATICA PHARMA INC EQ 375MG BASE N 020353 001 Jan 05, 1996 Aug CTEC >A> AB EQ 375MG BASE N 020353 001 Jan 05, 1996 Aug CTEC >D> EQ 500MG BASE N 020353 002 Jan 05, 1996 Aug CTEC >A> AB EQ 500MG BASE N 020353 002 Jan 05, 1996 Aug CTEC NAPROXEN SODIUM >D> @ ACTAVIS LABS FL INC EQ 375MG BASE A 075416 002 Apr 23, 2003 Aug CMFD >A> AB EQ 375MG BASE A 075416 002 Apr 23, 2003 Aug CMFD >D> @ EQ 500MG BASE A 075416 001 Aug 27, 2002 Aug CMFD >A> AB EQ 500MG BASE A 075416 001 Aug 27, 2002 Aug CMFD NEVIRAPINE TABLET;ORAL NEVIRAPINE >D> AB STRIDES ARCOLAB LTD 200MG A 078195 001 May 22, 2012 Aug CAHN >A> AB STRIDES PHARMA 200MG A 078195 001 May 22, 2012 Aug CAHN NITROFURANTOIN SUSPENSION;ORAL NITROFURANTOIN >A> AB NOVEL LABS INC 25MG/5ML A 201693 001 Sep 08, 2014 Aug NEWA NITROGLYCERIN FILM, EXTENDED RELEASE;TRANSDERMAL MINITRAN >D> AB1 MEDICIS 0.1MG/HR A 089771 001 Aug 30, 1996 Aug CAHN >D> AB1 0.6MG/HR A 089774 001 Aug 30, 1996 Aug CAHN >A> AB1 VALEANT PHARM NORTH 0.1MG/HR A 089771 001 Aug 30, 1996 Aug CAHN >A> AB1 0.6MG/HR A 089774 001 Aug 30, 1996 Aug CAHN OCTREOTIDE ACETATE INJECTABLE;INJECTION OCTREOTIDE ACETATE >D> AP + BEDFORD EQ 0.2MG BASE/ML A 076330 001 Apr 08, 2005 Aug CAHN >D> AP + EQ 1MG BASE/ML A 076330 002 Apr 08, 2005 Aug CAHN >A> AP + EUROHLTH INTL EQ 0.2MG BASE/ML A 076330 001 Apr 08, 2005 Aug CAHN >A> AP + EQ 1MG BASE/ML A 076330 002 Apr 08, 2005 Aug CAHN OCTREOTIDE ACETATE (PRESERVATIVE FREE) >D> AP + BEDFORD EQ 0.05MG BASE/ML A 076313 001 Mar 28, 2005 Aug CAHN >D> AP + EQ 0.1MG BASE/ML A 076313 003 Mar 28, 2005 Aug CAHN >D> AP + EQ 0.5MG BASE/ML A 076313 002 Mar 28, 2005 Aug CAHN >A> AP + EUROHLTH INTL EQ 0.05MG BASE/ML A 076313 001 Mar 28, 2005 Aug CAHN >A> AP + EQ 0.1MG BASE/ML A 076313 003 Mar 28, 2005 Aug CAHN >A> AP + EQ 0.5MG BASE/ML A 076313 002 Mar 28, 2005 Aug CAHN OLANZAPINE TABLET;ORAL OLANZAPINE >A> AB MACLEODS PHARMS LTD 2.5MG A 202862 001 Aug 15, 2014 Aug NEWA >A> AB 5MG A 202862 002 Aug 15, 2014 Aug NEWA >A> AB 7.5MG A 202862 003 Aug 15, 2014 Aug NEWA >A> AB 10MG A 202862 004 Aug 15, 2014 Aug NEWA >A> AB 15MG A 202862 005 Aug 15, 2014 Aug NEWA >A> AB 20MG A 202862 006 Aug 15, 2014 Aug NEWA ONDANSETRON FILM;ORAL ZUPLENZ >A> GALENA BIOPHARMA INC 4MG N 022524 001 Jul 02, 2010 Aug CAHN >A> + 8MG N 022524 002 Jul 02, 2010 Aug CAHN >D> VESTIQ PHARMS 4MG N 022524 001 Jul 02, 2010 Aug CAHN >D> + 8MG N 022524 002 Jul 02, 2010 Aug CAHN Page 17 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ONDANSETRON HYDROCHLORIDE INJECTABLE;INJECTION ONDANSETRON HYDROCHLORIDE >A> AP QILU PHARM CO LTD EQ 2MG BASE/ML A 203711 001 Sep 08, 2014 Aug NEWA >A> ORITAVANCIN DIPHOSPHATE >A> POWDER;IV (INFUSION) >A> ORBACTIV >A> + MEDICINES CO EQ 400MG BASE/VIAL N 206334 001 Aug 06, 2014 Aug NEWA ORPHENADRINE CITRATE INJECTABLE;INJECTION ORPHENADRINE CITRATE >D> AP BEDFORD LABS 30MG/ML A 040463 001 Mar 04, 2003 Aug CAHN >A> AP EUROHLTH INTL 30MG/ML A 040463 001 Mar 04, 2003 Aug CAHN OXACILLIN SODIUM INJECTABLE;INJECTION OXACILLIN SODIUM >A> AP AGILA SPECLTS EQ 1GM BASE/VIAL A 091486 001 Aug 25, 2014 Aug NEWA >A> AP EQ 2GM BASE/VIAL A 091486 002 Aug 25, 2014 Aug NEWA OXALIPLATIN INJECTABLE;IV (INFUSION) OXALIPLATIN >A> AP ACTAVIS ELIZABETH 50MG/VIAL A 078803 001 Aug 08, 2012 Aug CAHN >A> AP 100MG/VIAL A 078803 002 Aug 08, 2012 Aug CAHN >D> AP ACTAVIS TOTOWA 50MG/VIAL A 078803 001 Aug 08, 2012 Aug CAHN >D> AP 100MG/VIAL A 078803 002 Aug 08, 2012 Aug CAHN OXYCODONE HYDROCHLORIDE SOLUTION;ORAL OXYCODONE HYDROCHLORIDE >A> AA LANNETT HOLDINGS INC 100MG/5ML A 204085 001 Sep 09, 2014 Aug NEWA PACLITAXEL INJECTABLE;INJECTION PACLITAXEL >A> AP ACTAVIS ELIZABETH 6MG/ML A 090130 001 Dec 09, 2009 Aug CAHN >D> AP ACTAVIS TOTOWA 6MG/ML A 090130 001 Dec 09, 2009 Aug CAHN >D> AP BEDFORD 6MG/ML A 075190 001 Jan 28, 2002 Aug CAHN >A> AP EUROHLTH INTL 6MG/ML A 075190 001 Jan 28, 2002 Aug CAHN PAMIDRONATE DISODIUM INJECTABLE;INJECTION PAMIDRONATE DISODIUM >D> AP BEDFORD 30MG/VIAL A 075290 001 Apr 30, 2001 Aug CAHN >D> AP + 30MG/10ML (3MG/ML) N 021113 001 Mar 04, 2002 Aug CAHN >D> AP 90MG/VIAL A 075290 003 Apr 30, 2001 Aug CAHN >D> AP + 90MG/10ML (9MG/ML) N 021113 002 Mar 04, 2002 Aug CAHN >A> AP EUROHLTH INTL 30MG/VIAL A 075290 001 Apr 30, 2001 Aug CAHN >A> AP + 30MG/10ML (3MG/ML) N 021113 001 Mar 04, 2002 Aug CAHN >A> AP 90MG/VIAL A 075290 003 Apr 30, 2001 Aug CAHN >A> AP + 90MG/10ML (9MG/ML) N 021113 002 Mar 04, 2002 Aug CAHN PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE;ORAL PANTOPRAZOLE SODIUM >A> AB ACTAVIS ELIZABETH EQ 20MG BASE A 090797 001 Feb 07, 2011 Aug CAHN >A> AB EQ 40MG BASE A 090797 002 Feb 07, 2011 Aug CAHN >D> AB ACTAVIS TOTOWA EQ 20MG BASE A 090797 001 Feb 07, 2011 Aug CAHN >D> AB EQ 40MG BASE A 090797 002 Feb 07, 2011 Aug CAHN >A> AB HETERO LABS LTD V EQ 20MG BASE A 202882 001 Sep 10, 2014 Aug NEWA >A> AB EQ 40MG BASE A 202882 002 Sep 10, 2014 Aug NEWA Page 18 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST PEMOLINE TABLET, CHEWABLE;ORAL PEMOLINE >A> @ ACTAVIS ELIZABETH 37.5MG A 075678 001 Jul 26, 2000 Aug CAHN >D> @ ACTAVIS TOTOWA 37.5MG A 075678 001 Jul 26, 2000 Aug CAHN TABLET;ORAL PEMOLINE >A> @ ACTAVIS ELIZABETH 18.75MG A 075595 001 Feb 28, 2000 Aug CAHN >A> @ 37.5MG A 075595 002 Feb 28, 2000 Aug CAHN >A> @ 75MG A 075595 003 Feb 28, 2000 Aug CAHN >D> @ ACTAVIS TOTOWA 18.75MG A 075595 001 Feb 28, 2000 Aug CAHN >D> @ 37.5MG A 075595 002 Feb 28, 2000 Aug CAHN >D> @ 75MG A 075595 003 Feb 28, 2000 Aug CAHN PENTOSTATIN INJECTABLE;INJECTION PENTOSTATIN >D> AP BEDFORD LABS 10MG/VIAL A 077841 001 Aug 07, 2007 Aug CAHN >A> AP EUROHLTH INTL 10MG/VIAL A 077841 001 Aug 07, 2007 Aug CAHN PHENTOLAMINE MESYLATE INJECTABLE;INJECTION PHENTOLAMINE MESYLATE >D> AP BEDFORD 5MG/VIAL A 040235 001 Mar 11, 1998 Aug CAHN >A> AP EUROHLTH INTL 5MG/VIAL A 040235 001 Mar 11, 1998 Aug CAHN PIPERACILLIN SODIUM; TAZOBACTAM SODIUM INJECTABLE;INJECTION PIPERACILLIN AND TAZOBACTAM >A> AP AGILA SPECLTS EQ 2GM BASE/VIAL;EQ 250MG A 065458 001 Aug 15, 2014 Aug NEWA BASE/VIAL >A> AP EQ 3MG BASE/VIAL;EQ 375MG A 065458 002 Aug 15, 2014 Aug NEWA BASE/VIAL >A> AP EQ 4GM BASE/VIAL;EQ 500MG A 065458 003 Aug 15, 2014 Aug NEWA BASE/VIAL POLYMYXIN B SULFATE INJECTABLE;INJECTION POLYMYXIN B SULFATE >D> AP + BEDFORD EQ 500,000 U BASE/VIAL A 060716 001 Jun 29, 1964 Aug CAHN >A> AP + EUROHLTH INTL EQ 500,000 U BASE/VIAL A 060716 001 Jun 29, 1964 Aug CAHN POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE;ORAL KLOR-CON >D> UPSHER-SMITH LABS 8MEQ N 019123 001 Apr 17, 1986 Aug CTEC >A> AB2 8MEQ N 019123 001 Apr 17, 1986 Aug CTEC >D> BC + 10MEQ N 019123 002 Apr 17, 1986 Aug CTEC >A> AB2 + 10MEQ N 019123 002 Apr 17, 1986 Aug CTEC KLOR-CON M10 >D> AB UPSHER SMITH LABS 10MEQ A 074726 002 Aug 09, 2000 Aug CTEC >A> AB1 10MEQ A 074726 002 Aug 09, 2000 Aug CTEC KLOR-CON M20 >D> AB + UPSHER SMITH LABS 20MEQ A 074726 001 Nov 20, 1998 Aug CTEC >A> AB1 + 20MEQ A 074726 001 Nov 20, 1998 Aug CTEC POTASSIUM CHLORIDE >D> AB ACTAVIS LABS FL INC 10MEQ A 075604 001 Apr 10, 2002 Aug CTEC >A> AB1 10MEQ A 075604 001 Apr 10, 2002 Aug CTEC >D> AB 20MEQ A 075604 002 Apr 10, 2002 Aug CTEC >A> AB1 20MEQ A 075604 002 Apr 10, 2002 Aug CTEC >D> AB EURAND 20MEQ A 076368 001 Aug 18, 2004 Aug CTEC >A> AB1 20MEQ A 076368 001 Aug 18, 2004 Aug CTEC >A> AB2 MYLAN PHARMS INC 8.0MEQ A 204662 001 Aug 21, 2014 Aug NEWA >A> AB2 10.0MEQ A 204662 002 Aug 21, 2014 Aug NEWA Page 19 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST PRAMIPEXOLE DIHYDROCHLORIDE TABLET;ORAL PRAMIPEXOLE DIHYDROCHLORIDE >D> AB STRIDES ARCOLAB LTD 0.125MG A 202702 001 Jun 03, 2014 Aug CAHN >D> AB 0.25MG A 202702 002 Jun 03, 2014 Aug CAHN >D> AB 0.5MG A 202702 003 Jun 03, 2014 Aug CAHN >D> AB 0.75MG A 202702 004 Jun 03, 2014 Aug CAHN >D> AB 1MG A 202702 005 Jun 03, 2014 Aug CAHN >D> AB 1.5MG A 202702 006 Jun 03, 2014 Aug CAHN >A> AB STRIDES PHARMA 0.125MG A 202702 001 Jun 03, 2014 Aug CAHN >A> AB 0.25MG A 202702 002 Jun 03, 2014 Aug CAHN >A> AB 0.5MG A 202702 003 Jun 03, 2014 Aug CAHN >A> AB 0.75MG A 202702 004 Jun 03, 2014 Aug CAHN >A> AB 1MG A 202702 005 Jun 03, 2014 Aug CAHN >A> AB 1.5MG A 202702 006 Jun 03, 2014 Aug CAHN PRAVASTATIN SODIUM TABLET;ORAL PRAVASTATIN SODIUM >D> @ SANDOZ 80MG A 077491 001 Feb 11, 2008 Aug CMFD >A> AB 80MG A 077491 001 Feb 11, 2008 Aug CMFD PROPOFOL INJECTABLE;INJECTION PROPOFOL >D> @ BEDFORD 10MG/ML A 074848 001 Apr 19, 2005 Aug CAHN >A> @ EUROHLTH INTL 10MG/ML A 074848 001 Apr 19, 2005 Aug CAHN PROPOXYPHENE HYDROCHLORIDE >D> CAPSULE;ORAL >D> PROPOXYPHENE HYDROCHLORIDE >D> MUTUAL PHARM 65MG A 083186 001 Dec 18, 1972 Aug DISC >A> @ 65MG A 083186 001 Dec 18, 1972 Aug DISC PYRIDOSTIGMINE BROMIDE SYRUP;ORAL MESTINON >D> + VALEANT PHARM INTL 60MG/5ML N 015193 001 Jan 25, 1965 Aug CAHN >A> + VALEANT PHARM NORTH 60MG/5ML N 015193 001 Jan 25, 1965 Aug CAHN QUINAPRIL HYDROCHLORIDE TABLET;ORAL QUINAPRIL HYDROCHLORIDE >A> @ ACTAVIS ELIZABETH EQ 5MG BASE A 076459 001 Dec 22, 2004 Aug CAHN >A> @ EQ 10MG BASE A 076459 002 Dec 22, 2004 Aug CAHN >A> @ EQ 20MG BASE A 076459 003 Dec 22, 2004 Aug CAHN >A> @ EQ 40MG BASE A 076459 004 Dec 22, 2004 Aug CAHN >D> @ ACTAVIS TOTOWA EQ 5MG BASE A 076459 001 Dec 22, 2004 Aug CAHN >D> @ EQ 10MG BASE A 076459 002 Dec 22, 2004 Aug CAHN >D> @ EQ 20MG BASE A 076459 003 Dec 22, 2004 Aug CAHN >D> @ EQ 40MG BASE A 076459 004 Dec 22, 2004 Aug CAHN RANITIDINE HYDROCHLORIDE INJECTABLE;INJECTION RANITIDINE HYDROCHLORIDE >D> AP BEDFORD EQ 25MG BASE/ML A 077458 001 Feb 16, 2006 Aug CAHN >D> AP BEN VENUE EQ 25MG BASE/ML A 074777 001 Mar 02, 2005 Aug CAHN >A> AP EUROHLTH INTL EQ 25MG BASE/ML A 074777 001 Mar 02, 2005 Aug CAHN >A> AP EQ 25MG BASE/ML A 077458 001 Feb 16, 2006 Aug CAHN REPAGLINIDE TABLET;ORAL REPAGLINIDE >A> AB ACTAVIS ELIZABETH 0.5MG A 090008 001 Jan 22, 2014 Aug CAHN >A> AB 1MG A 090008 002 Jan 22, 2014 Aug CAHN >A> AB 2MG A 090008 003 Jan 22, 2014 Aug CAHN >D> AB ACTAVIS TOTOWA 0.5MG A 090008 001 Jan 22, 2014 Aug CAHN >D> AB 1MG A 090008 002 Jan 22, 2014 Aug CAHN >D> AB 2MG A 090008 003 Jan 22, 2014 Aug CAHN Page 20 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST RIBAVIRIN TABLET;ORAL RIBAVIRIN >A> AB SANDOZ 200MG A 202546 001 Aug 12, 2014 Aug NEWA >A> AB 400MG A 202546 002 Aug 12, 2014 Aug NEWA >A> AB 500MG A 202546 003 Aug 12, 2014 Aug NEWA >A> AB 600MG A 202546 004 Aug 12, 2014 Aug NEWA >D> ZYDUS PHARMS USA 500MG A 077094 004 Apr 18, 2008 Aug CTEC >A> AB 500MG A 077094 004 Apr 18, 2008 Aug CTEC RIFAMPIN INJECTABLE;INJECTION RIFAMPIN >A> AP EMCURE PHARMS LTD 600MG/VIAL A 204101 001 Aug 18, 2014 Aug NEWA >A> AP FRESENIUS KABI USA 600MG/VIAL A 091181 001 Aug 21, 2014 Aug NEWA RIMANTADINE HYDROCHLORIDE TABLET;ORAL RIMANTADINE HYDROCHLORIDE >A> @ ACTAVIS ELIZABETH 100MG A 076375 001 Jan 14, 2003 Aug CAHN >D> @ ACTAVIS TOTOWA 100MG A 076375 001 Jan 14, 2003 Aug CAHN RIVASTIGMINE TARTRATE CAPSULE;ORAL RIVASTIGMINE TARTRATE >A> AB MACLEODS PHARMS LTD EQ 1.5MG BASE A 203148 001 Aug 22, 2014 Aug NEWA >A> AB EQ 3MG BASE A 203148 002 Aug 22, 2014 Aug NEWA >A> AB EQ 4.5MG BASE A 203148 003 Aug 22, 2014 Aug NEWA >A> AB EQ 6MG BASE A 203148 004 Aug 22, 2014 Aug NEWA SELENIUM SULFIDE LOTION/SHAMPOO;TOPICAL SELENIUM SULFIDE >A> @ G AND W LABS INC 2.5% A 086209 001 Nov 04, 1981 Aug CAHN >D> @ TARO 2.5% A 086209 001 Nov 04, 1981 Aug CAHN SPIRONOLACTONE TABLET;ORAL SPIRONOLACTONE >A> AB JUBILANT GENERICS 25MG A 203253 001 Apr 23, 2014 Aug CAHN >A> AB 50MG A 203253 002 Apr 23, 2014 Aug CAHN >A> AB 100MG A 203253 003 Apr 23, 2014 Aug CAHN >D> AB JUBILANT LIFE 25MG A 203253 001 Apr 23, 2014 Aug CAHN >D> AB 50MG A 203253 002 Apr 23, 2014 Aug CAHN >D> AB 100MG A 203253 003 Apr 23, 2014 Aug CAHN SUMATRIPTAN SUCCINATE INJECTABLE;SUBCUTANEOUS SUMAVEL DOSEPRO >A> BX + ENDO VENTURES LTD EQ 4MG BASE/0.5ML (EQ 8MG N 022239 002 Nov 26, 2013 Aug CAHN BASE/ML) >A> BX + EQ 6MG BASE/0.5ML (EQ 12MG N 022239 001 Jul 15, 2009 Aug CAHN BASE/ML) >D> BX + ZOGENIX INC EQ 4MG BASE/0.5ML (EQ 8MG N 022239 002 Nov 26, 2013 Aug CAHN BASE/ML) >D> BX + EQ 6MG BASE/0.5ML (EQ 12MG N 022239 001 Jul 15, 2009 Aug CAHN BASE/ML) >A> SUVOREXANT >A> TABLET;ORAL >A> BELSOMRA >A> MERCK SHARP DOHME 5MG N 204569 001 Aug 13, 2014 Aug NEWA >A> 10MG N 204569 002 Aug 13, 2014 Aug NEWA >A> 15MG N 204569 003 Aug 13, 2014 Aug NEWA >A> + 20MG N 204569 004 Aug 13, 2014 Aug NEWA Page 21 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST TACROLIMUS CAPSULE;ORAL TACROLIMUS >D> AB STRIDES ARCOLAB LTD EQ 0.5MG BASE A 090687 001 Jul 22, 2014 Aug CAHN >D> AB EQ 1MG BASE A 090687 002 Jul 22, 2014 Aug CAHN >D> AB EQ 5MG BASE A 090687 003 Jul 22, 2014 Aug CAHN >A> AB STRIDES PHARMA EQ 0.5MG BASE A 090687 001 Jul 22, 2014 Aug CAHN >A> AB EQ 1MG BASE A 090687 002 Jul 22, 2014 Aug CAHN >A> AB EQ 5MG BASE A 090687 003 Jul 22, 2014 Aug CAHN OINTMENT;TOPICAL PROTOPIC >D> + ASTELLAS 0.03% N 050777 001 Dec 08, 2000 Aug CFTG >A> AB + 0.03% N 050777 001 Dec 08, 2000 Aug CFTG >D> + 0.1% N 050777 002 Dec 08, 2000 Aug CFTG >A> AB + 0.1% N 050777 002 Dec 08, 2000 Aug CFTG >A> TACROLIMUS >A> AB FOUGERA PHARMS INC 0.03% A 200744 001 Sep 09, 2014 Aug NEWA >A> AB 0.1% A 200744 002 Sep 09, 2014 Aug NEWA TELMISARTAN TABLET;ORAL TELMISARTAN >A> AB ZYDUS PHARMS USA INC 20MG A 203325 001 Aug 26, 2014 Aug NEWA >A> AB 40MG A 203325 002 Aug 26, 2014 Aug NEWA >A> AB 80MG A 203325 003 Aug 26, 2014 Aug NEWA TESAMORELIN ACETATE POWDER;SUBCUTANEOUS EGRIFTA >D> @ THERATECHNOLOGIES EQ 1MG BASE/VIAL N 022505 001 Nov 10, 2010 Aug CMFD >A> + EQ 1MG BASE/VIAL N 022505 001 Nov 10, 2010 Aug CMFD >D> + EQ 2MG BASE/VIAL N 022505 002 Nov 29, 2011 Aug DISC >A> @ EQ 2MG BASE/VIAL N 022505 002 Nov 29, 2011 Aug DISC THIOTEPA INJECTABLE;INJECTION THIOTEPA >D> BEDFORD 15MG/VIAL A 075547 001 Apr 02, 2001 Aug CAHN >A> EUROHLTH INTL 15MG/VIAL A 075547 001 Apr 02, 2001 Aug CAHN TOPOTECAN HYDROCHLORIDE INJECTABLE;INJECTION TOPOTECAN HYDROCHLORIDE >A> AP ACTAVIS ELIZABETH EQ 4MG BASE/VIAL A 090620 001 Dec 02, 2010 Aug CAHN >D> AP ACTAVIS TOTOWA EQ 4MG BASE/VIAL A 090620 001 Dec 02, 2010 Aug CAHN TORSEMIDE INJECTABLE;INJECTION TORSEMIDE >D> AP + BEDFORD LABS 20MG/2ML (10MG/ML) A 078007 001 Jun 11, 2008 Aug CAHN >D> AP + 50MG/5ML (10MG/ML) A 078007 002 Jun 11, 2008 Aug CAHN >A> AP + EUROHLTH INTL 20MG/2ML (10MG/ML) A 078007 001 Jun 11, 2008 Aug CAHN >A> AP + 50MG/5ML (10MG/ML) A 078007 002 Jun 11, 2008 Aug CAHN TRANEXAMIC ACID INJECTABLE;INJECTION TRANEXAMIC ACID >A> AP EMCURE PHARMS LTD 100MG/ML A 203521 001 Aug 12, 2014 Aug NEWA TRIAMCINOLONE ACETONIDE LOTION;TOPICAL TRIAMCINOLONE ACETONIDE >A> @ G AND W LABS INC 0.1% A 089129 001 Aug 14, 1986 Aug CAHN >D> @ TARO 0.1% A 089129 001 Aug 14, 1986 Aug CAHN UNOPROSTONE ISOPROPYL SOLUTION/DROPS;OPHTHALMIC RESCULA >D> SUCAMPO PHARMS 0.15% N 021214 001 Aug 03, 2000 Aug CRLD >A> + 0.15% N 021214 001 Aug 03, 2000 Aug CRLD Page 22 of 24 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST VALACYCLOVIR HYDROCHLORIDE TABLET;ORAL VALACYCLOVIR HYDROCHLORIDE >A> AB JUBILANT GENERICS EQ 1GM BASE A 201506 002 Apr 03, 2012 Aug CAHN >A> AB EQ 500MG BASE A 201506 001 Apr 03, 2012 Aug CAHN >D> AB JUBILANT ORGANOSYS EQ 1GM BASE A 201506 002 Apr 03, 2012 Aug CAHN >D> AB EQ 500MG BASE A 201506 001 Apr 03, 2012 Aug CAHN VANCOMYCIN HYDROCHLORIDE CAPSULE;ORAL VANCOCIN HYDROCHLORIDE >A> AB ANI PHARMS INC EQ 125MG BASE N 050606 001 Apr 15, 1986 Aug CAHN >A> AB + EQ 250MG BASE N 050606 002 Apr 15, 1986 Aug CAHN >D> AB SHIRE VIROPHARM INC EQ 125MG BASE N 050606 001 Apr 15, 1986 Aug CAHN >D> AB + EQ 250MG BASE N 050606 002 Apr 15, 1986 Aug CAHN VANCOMYCIN HYDROCHLORIDE >D> AB STRIDES ARCOLAB LTD EQ 125MG BASE A 065490 001 Apr 09, 2012 Aug CAHN >D> AB EQ 250MG BASE A 065490 002 Apr 09, 2012 Aug CAHN >A> AB STRIDES PHARMA EQ 125MG BASE A 065490 001 Apr 09, 2012 Aug CAHN >A> AB EQ 250MG BASE A 065490 002 Apr 09, 2012 Aug CAHN FOR SOLUTION;ORAL VANCOCIN HYDROCHLORIDE >A> @ ANI PHARMS INC EQ 250MG BASE/5ML A 061667 002 Jul 13, 1983 Aug CAHN >A> @ EQ 500MG BASE/6ML A 061667 001 Jul 24, 1972 Aug CAHN >D> @ VIROPHARMA EQ 250MG BASE/5ML A 061667 002 Jul 13, 1983 Aug CAHN >D> @ EQ 500MG BASE/6ML A 061667 001 Jul 24, 1972 Aug CAHN INJECTABLE;INJECTION VANCOCIN HYDROCHLORIDE >A> @ ANI PHARMS INC EQ 1GM BASE/VIAL A 060180 002 Mar 21, 1986 Aug CAHN >A> @ EQ 1GM BASE/VIAL A 062476 002 Mar 21, 1986 Aug CAHN >A> @ EQ 1GM BASE/VIAL A 062716 002 Mar 13, 1987 Aug CAHN >A> @ EQ 1GM BASE/VIAL A 062812 002 Nov 17, 1987 Aug CAHN >A> @ EQ 10GM BASE/VIAL A 062812 003 Nov 17, 1987 Aug CAHN >A> @ EQ 500MG BASE/VIAL A 060180 001 Nov 06, 1964 Aug CAHN >A> @ EQ 500MG BASE/VIAL A 062476 001 Mar 15, 1984 Aug CAHN >A> @ EQ 500MG BASE/VIAL A 062716 001 Mar 13, 1987 Aug CAHN >A> @ EQ 500MG BASE/VIAL A 062812 001 Nov 17, 1987 Aug CAHN >D> @ VIROPHARMA EQ 1GM BASE/VIAL A 060180 002 Mar 21, 1986 Aug CAHN >D> @ EQ 1GM BASE/VIAL A 062476 002 Mar 21, 1986 Aug CAHN >D> @ EQ 1GM BASE/VIAL A 062716 002 Mar 13, 1987 Aug CAHN >D> @ EQ 1GM BASE/VIAL A 062812 002 Nov 17, 1987 Aug CAHN >D> @ EQ 10GM BASE/VIAL A 062812 003 Nov 17, 1987 Aug CAHN >D> @ EQ 500MG BASE/VIAL A 060180 001 Nov 06, 1964 Aug CAHN >D> @ EQ 500MG BASE/VIAL A 062476 001 Mar 15, 1984 Aug CAHN >D> @ EQ 500MG BASE/VIAL A 062716 001 Mar 13, 1987 Aug CAHN >D> @ EQ 500MG BASE/VIAL A 062812 001 Nov 17, 1987 Aug CAHN VANCOMYCIN HYDROCHLORIDE >A> AP SAGENT PHARMS EQ 10GM BASE/VIAL A 200837 002 Sep 02, 2014 Aug NEWA VINBLASTINE SULFATE INJECTABLE;INJECTION VINBLASTINE SULFATE >D> + BEDFORD 10MG/VIAL A 089395 001 Apr 09, 1987 Aug CAHN >A> + EUROHLTH INTL 10MG/VIAL A 089395 001 Apr 09, 1987 Aug CAHN VINORELBINE TARTRATE INJECTABLE;INJECTION VINORELBINE TARTRATE >A> AP ACTAVIS ELIZABETH EQ 10MG BASE/ML A 078011 001 Jul 22, 2009 Aug CAHN >D> AP ACTAVIS TOTOWA EQ 10MG BASE/ML A 078011 001 Jul 22, 2009 Aug CAHN ZOLEDRONIC ACID INJECTABLE;IV (INFUSION) ZOLEDRONIC ACID >A> AP AKORN EQ 5MG BASE/100ML A 200918 001 Aug 21, 2014 Aug NEWA >A> AP USV NORTH AMERICA EQ 4MG BASE/VIAL A 202923 001 Sep 04, 2014 Aug NEWA Page 23 of 24 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN CAPSULE;ORAL IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE >D> STRIDES ARCOLAB LTD 25MG;EQ 200MG FREE ACID AND A 200888 001 Mar 05, 2012 Aug CAHN POTASSIUM SALT >A> STRIDES PHARMA 25MG;EQ 200MG FREE ACID AND A 200888 001 Mar 05, 2012 Aug CAHN POTASSIUM SALT LEVONORGESTREL TABLET;ORAL LEVONORGESTREL >A> PERRIGO R AND D 1.5MG A 202334 001 Aug 20, 2014 Aug NEWA NONOXYNOL-9 SPONGE;VAGINAL TODAY >D> + AZTIQ PHARMA 1GM N 018683 001 Apr 01, 1983 Aug CAHN >A> + MAYER LABS INC 1GM N 018683 001 Apr 01, 1983 Aug CAHN CURRENT MONTH ADDS/DELETES LIST NOTE: The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name. The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred. New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA. Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>. The change code description: NEWA New drug product approval usually in the supplement month. CAHN Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition. Page 24 of 24